EXPIRED: Attomarker

Attomarker Ltd is a nanophotonic biochemical testing Company, founded in 2008, spun out from Professor Andrew Shaw’s research group at the University of Exeter. The core nanotechnology was developed following a UK Government grant for £2.5m and Attomarker was set up to develop the intellectual property, with the University as a shareholder. In 2015, Attomarker won EU funding to demonstrate that the nanotechnology could be deployed using an iPhone camera and processor; a first prototype was developed following a £500k seed funding round from the British Innovation Fund in 2017

The Company is seeking up to £5m, with £2m providing the necessary support to roll-out the Liscar 6 Covid testing in the UK and initiate FDA approval, and a further £3m to deliver a CE marked handheld device and the first non-Covid tests to the clinic.

Currently raising funds via SETsquared Partnership.

Healthcare